Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men (NCT07328542)
A Multi-center, Open-label, Single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Study of Testosterone Cypionate Injection in Hypogonadal Men
🩺 Plain-English Summary (8th-Grade Level)
A Phase 4, multi-center, open-label, single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) study of Testosterone Cypionate Injection in Hypogonadal Men to assess change in 24-hour ambulatory blood pressure from Baseline to End of Treatment
Who can join: Review the eligibility criteria below.
Location: Alabama Clinical Therapeutics, LLC — Birmingham, Alabama
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- Alabama Clinical Therapeutics, LLC — Birmingham, Alabama
- Hillcrest Medical Research, LLC — DeLand, Florida
- Integrity Clinical Research Center, Inc. — Hialeah, Florida
- AccuMed Research Associates — Garden City, New York
- Aim Trials — Plano, Texas
- Alpine Clinical Organization Inc. — Clinton, Utah
📞 Contact the Study Coordinator
Phone: (913) 389-7961
Email: david.sequeira@azurity.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hypogonadism, Male
- TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation — Los Angeles, California
- Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency — Augusta, Georgia
- 52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism — Los Angeles, California
- Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone — Boston, Massachusetts
- Testosterone Treatment in Men With Chronic Kidney Disease — St Louis, Missouri
Explore by condition: All Hypogonadism, Male clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.